Skip to main content
Have a personal or library account? Click to login
Epigenetic Regulation of Angiogenesis in Peripheral Artery Disease Cover

Epigenetic Regulation of Angiogenesis in Peripheral Artery Disease

Open Access
|Nov 2023

References

  1. Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013 Oct 19;382(9901):1329-40. doi: 10.1016/S0140-6736(13)61249-0
  2. Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006 Mar 7;47(5):921-9. doi: 10.1016/j.jacc.2005.09.065
  3. Nehler MR, Duval S, Diao L, et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg. 2014 Sep;60(3):686-95 e2. doi: 10.1016/j.jvs.2014.03.290
  4. Duff S, Mafilios MS, Bhounsule P, Hasegawa JT. The burden of critical limb ischemia: a review of recent literature. Vasc Health Risk Manag. 2019 Jul 1;15:187-208. doi: 10.2147/VHRM.S209241
  5. Farber A. Chronic Limb-Threatening Ischemia. N Engl J Med. 2018 Jul 12;379(2):171-80. doi: 10.1056/NEJMcp1709326
  6. Farber A, Menard MT, Conte MS, et al. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. N Engl J Med. 2022 Dec 22;387(25):2305-16. doi: 10.1056/NEJMoa2207899
  7. Shishehbor MH, Powell RJ, Montero-Baker MF, et al. Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia. N Engl J Med. 2023 Mar 30;388(13):1171-80. doi: 10.1056/NEJMoa2212754
  8. Iyer SR, Annex BH. Therapeutic Angiogenesis for Peripheral Artery Disease: Lessons Learned in Translational Science. JACC Basic Transl Sci. 2017 Oct;2(5):503-12. doi: 10.1016/j.jacbts.2017.07.012
  9. Cooke JP, Losordo DW. Modulating the vascular response to limb ischemia: angiogenic and cell therapies. Circ Res. 2015 Apr 24;116(9):1561-78. doi: 10.1161/CIRCRESAHA.115.303565
  10. Chen Z, Li S, Subramaniam S, Shyy JY, Chien S. Epigenetic Regulation: A New Frontier for Biomedical Engineers. Annu Rev Biomed Eng. 2017 Jun 21;19:195-219. doi: 10.1146/annurev-bioeng-071516-044720
  11. Morselli M, Dieci G. Epigenetic regulation of human non-coding RNA gene transcription. Biochem Soc Trans. 2022 Apr 29;50(2):723-36. doi: 10.1042/BST20210860
  12. Allis CD, Jenuwein T. The molecular hallmarks of epigenetic control. Nat Rev Genet. 2016 Aug;17(8):487-500. doi: 10.1038/nrg.2016.59
  13. Fitz-James MH, Cavalli G. Molecular mechanisms of transgenerational epigenetic inheritance. Nat Rev Genet. 2022 Jun;23(6):325-41. doi: 10.1038/s41576-021-00438-5
  14. Krishna SM, Dear A, Craig JM, Norman PE, Golledge J. The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation. Atherosclerosis. 2013 Jun;228(2):295-305. doi: 10.1016/j.atherosclerosis.2013.02.019
  15. Cao Q, Wang X, Jia L, et al. Inhibiting DNA Methylation by 5-Aza-2’-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology. 2014 Dec;155(12):4925-38. doi: 10.1210/en.2014-1595
  16. Vinh A, Gaspari TA, Liu HB, Dousha LF, Widdop RE, Dear AE. A novel histone deacetylase inhibitor reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. J Vasc Res. 2008;45(2):143-52. doi: 10.1159/000110041
  17. Marahrens Y, Panning B, Dausman J, Strauss W, Jaenisch R. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes Dev. 1997 Jan 15;11(2):156-66. doi: 10.1101/gad.11.2.156
  18. Penny GD, Kay GF, Sheardown SA, Rastan S, Brockdorff N. Requirement for Xist in X chromosome inactivation. Nature. 1996 Jan 11;379(6561):131-7. doi: 10.1038/379131a0
  19. Statello L, Guo CJ, Chen LL, Huarte M. Author Correction: Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021 Feb;22(2):159. doi: 10.1038/s41580-021-00330-4
  20. Kopp F, Mendell JT. Functional Classification and Experimental Dissection of Long Noncoding RNAs. Cell. 2018 Jan 25;172(3):393-407. doi: 10.1016/j.cell.2018.01.011
  21. Rinn JL, Chang HY. Long Noncoding RNAs: Molecular Modalities to Organismal Functions. Annu Rev Biochem. 2020 Jun 20;89:283-308. doi: 10.1146/annurev-biochem-062917-012708
  22. Mattick JS, Amaral PP, Carninci P, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023 Jun;24(6):430-47. doi: 10.1038/s41580-022-00566-8
  23. Perez-Cremades D, Cheng HS, Feinberg MW. Noncoding RNAs in Critical Limb Ischemia. Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):523-33. doi: 10.1161/ATVBAHA.119.312860
  24. Michalik KM, You X, Manavski Y, et al. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res. 2014 Apr 25;114(9):1389-97. doi: 10.1161/CIRCRESAHA.114.303265
  25. Zhang X, Tang X, Hamblin MH, Yin KJ. Long Non-Coding RNA Malat1 Regulates Angiogenesis in Hindlimb Ischemia. Int J Mol Sci. 2018 Jun 11;19(6). doi: 10.3390/ijms19061723
  26. Cremer S, Michalik KM, Fischer A, et al. Hematopoietic Deficiency of the Long Noncoding RNA MALAT1 Promotes Atherosclerosis and Plaque Inflammation. Circulation. 2019 Mar 5;139(10):1320-34. doi: 10.1161/CIRCULATIONAHA.117.029015
  27. Kuang L, Zhang C, Li B, Deng H, Chen R, Li G. Human Keratinocyte-Derived Exosomal MALAT1 Promotes Diabetic Wound Healing by Upregulating MFGE8 via microRNA-1914-3p. Int J Nanomedicine. 2023 Feb 21;18:949-70. doi: 10.2147/IJN.S399785. eCollection 2023
  28. Liu JY, Yao J, Li XM, et al. Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus. Cell Death Dis. 2014 Oct 30;5(10):e1506. doi: 10.1038/cddis.2014.466
  29. Boon RA, Hofmann P, Michalik KM, et al. Long Noncoding RNA Meg3 Controls Endothelial Cell Aging and Function: Implications for Regenerative Angiogenesis. J Am Coll Cardiol. 2016 Dec 13;68(23):2589-91. doi: 10.1016/j.jacc.2016.09.949
  30. Wu Z, He Y, Li D, et al. Long noncoding RNA MEG3 suppressed endothelial cell proliferation and migration through regulating miR-21. Am J Transl Res. 2017 Jul 15;9(7):3326-35. PMID: 28804550
  31. Liu LZ, Li C, Chen Q, et al. MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression. PLoS One. 2011 Apr 22;6(4):e19139. doi: 10.1371/journal.pone.0019139
  32. Gordon FE, Nutt CL, Cheunsuchon P, et al. Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology. 2010 Jun;151(6):2443-52. doi: 10.1210/en.2009-1151
  33. Kameswaran V, Bramswig NC, McKenna LB, et al. Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab. 2014 Jan 17;19(1):135-45. doi: 10.1016/j.cmet.2013.11.016
  34. Aavik E, Lumivuori H, Leppanen O, et al. Global DNA methylation analysis of human atherosclerotic plaques reveals extensive genomic hypomethylation and reactivation at imprinted locus 14q32 involving induction of a miRNA cluster. Eur Heart J. 2015 Apr 21;36(16):993-1000. doi: 10.1093/eurheartj/ehu437
  35. Heuslein JL, Gorick CM, Price RJ. Epigenetic regulators of the revascularization response to chronic arterial occlusion. Cardiovasc Res. 2019 Mar 15;115(4):701-12. doi: 10.1093/cvr/cvz001
  36. Broadbent HM, Peden JF, Lorkowski S, et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet. 2008 Mar 15;17(6):806-14. doi: 10.1093/hmg/ddm352
  37. Ye S, Willeit J, Kronenberg F, Xu Q, Kiechl S. Association of genetic variation on chromosome 9p21 with susceptibility and progression of atherosclerosis: a population-based, prospective study. J Am Coll Cardiol. 2008 Jul 2952(5):378-84. doi: 10.1016/j.jacc.2007.11.087
  38. Razeghian-Jahromi I, Karimi Akhormeh A, Zibaeenezhad MJ. The Role of ANRIL in Atherosclerosis. Dis Markers. 2022 Feb 9;2022:8859677. doi: 10.1155/2022/8859677
  39. Su H, Liu B, Chen H, et al. LncRNA ANRIL mediates endothelial dysfunction through BDNF downregulation in chronic kidney disease. Cell Death Dis. 2022 Jul 29;13(7):661. doi: 10.1038/s41419-022-05068-1
  40. Liu X, Li S, Yang Y, et al. The lncRNA ANRIL regulates endothelial dysfunction by targeting the let-7b/TGF-betaR1 signalling pathway. J Cell Physiol. 2021 Mar;236(3):2058-69. doi: 10.1002/jcp.29993
  41. Wufuer A, Luohemanjiang X, Du L, et al. ANRIL overexpression globally induces expression and alternative splicing of genes involved in inflammation in HUVECs. Mol Med Rep. 2023 Feb;27(2). doi: 10.3892/mmr.2022.12915
  42. Huang Q, Pan M, Zhou JP, Yin F. Overexpression of long non-coding RNA ANRIL promotes post-ischaemic angiogenesis and improves cardiac functions by targeting Akt. J Cell Mol Med. 2020 Jun;24(12):6860-8. doi: 10.1111/jcmm.15343
  43. Nanda V, Downing KP, Ye J, et al. CDKN2B Regulates TGFbeta Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels. Circ Res. 2016 Jan 22;118(2):230-40. doi: 10.1161/CIRCRESAHA.115.307906
  44. Haemmig S, Yang D, Sun X, et al. Long noncoding RNA SNHG12 integrates a DNA-PK-mediated DNA damage response and vascular senescence. Sci Transl Med. 2020 Feb 19;12(531). doi: 10.1126/scitranslmed.aaw1868
  45. Gross DA, Cheng HS, Zhuang R, et al. Deficiency of lncRNA SNHG12 impairs ischemic limb neovascularization by altering an endothelial cell cycle pathway. JCI Insight. 2022 Jan 11;7(1). doi: 10.1172/jci.insight.150761
  46. Miao Y, Ajami NE, Huang TS, et al. Enhancer-associated long non-coding RNA LEENE regulates endothelial nitric oxide synthase and endothelial function. Nat Commun. 2018 Jan 18;9(1):292. doi: 10.1038/s41467-017-02113-y
  47. Stanicek L, Lozano-Vidal N, Bink DI, et al. Long non-coding RNA LASSIE regulates shear stress sensing and endothelial barrier function. Commun Biol. 2020 May 26;3(1):265. doi: 10.1038/s42003-020-0987-0
  48. Tang X, Luo Y, Yuan D, et al. Long noncoding RNA LEENE promotes angiogenesis and ischemic recovery in diabetes models. J Clin Invest. 2023 Feb 1;133(3). doi: 10.1172/JCI161759
  49. Kallapur A, Sallam T. Endothelial cells LEENE on noncoding RNAs in diabetic vasculopathy. J Clin Invest. 2023 Feb 1;133(3). doi: 10.1172/JCI167047
  50. Man HSJ, Sukumar AN, Lam GC, et al. Angiogenic patterning by STEEL, an endothelial-enriched long noncoding RNA. Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2401-6. doi: 10.1073/pnas.1715182115
  51. Zhang SZ, Lu ZF, Xu YJ, Shi HF, Liu YZ, Rui YJ. STEEL participates in fracture healing through upregulating angiogenesis-related genes by recruiting PARP 1. Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3669-75. doi: 10.26355/eurrev_201806_15245
  52. Yu B, Wang S. Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease. Theranostics. 2018 Jun 8;8(13):3654-75. doi: 10.7150/thno.26024
  53. Hofmann P, Sommer J, Theodorou K, et al. Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signalling. Cardiovasc Res. 2019 Jan 1;115(1):230-42. doi: 10.1093/cvr/cvy206
  54. Voellenkle C, Garcia-Manteiga JM, Pedrotti S, et al. Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. Sci Rep. 2016 Apr 11;6:24141. doi: 10.1038/srep24141
  55. Boos F, Oo JA, Warwick T, et al. The endothelial-enriched lncRNA LINC00607 mediates angiogenic function. Basic Res Cardiol. 2023 Jan 26;118(1):5. doi: 10.1007/s00395-023-00978-3
  56. Calandrelli R, Xu L, Luo Y, et al. Stress-induced RNA-chromatin interactions promote endothelial dysfunction. Nat Commun. 2020 Oct 15;11(1):5211. doi: 10.1038/s41467-020-18957-w
  57. Cullina S, Wojcik GL, Shemirani R, et al. Admixture Mapping of Peripheral Artery Disease in a Dominican Population Reveals a Novel Risk Locus on 2q35. Front Genet. 2023 Aug 1:14:1181167. doi: 10.3389/fgene.2023.1181167
  58. He Q, Tan J, Yu B, Shi W, Liang K. Long noncoding RNA HIF1A-AS1A reduces apoptosis of vascular smooth muscle cells: implications for the pathogenesis of thoracoabdominal aorta aneurysm. Pharmazie. 2015 May;70(5):310-5. PMID: 26062299
  59. Wang S, Zhang X, Yuan Y, et al. BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro. Eur J Cardiothorac Surg. 2015 Mar;47(3):439-46. doi: 10.1093/ejcts/ezu215
  60. Boulberdaa M, Scott E, Ballantyne M, et al. A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells. Mol Ther. 2016 May;24(5):978-90. doi: 10.1038/mt.2016.41
  61. Wang X, Li Q, He S, et al. LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation. Mol Med. 2022 Oct 25;28(1):126. doi: 10.1186/s10020-022-00551-z
  62. Li P, Xing J, Zhang J, et al. Inhibition of long noncoding RNA HIF1A-AS2 confers protection against atherosclerosis via ATF2 downregulation. J Adv Res. 2020 Jul 31;26:123-35. doi: 10.1016/j.jare.2020.07.015
  63. Shu L, Wang C, Ding Z, et al. A novel regulated network mediated by downregulation HIF1A-AS2 lncRNA impairs placental angiogenesis by promoting ANGPTL4 expression in preeclampsia. Front Cell Dev Biol. 2022 Aug 9;10:837000. doi: 10.3389/fcell.2022.837000
  64. Sayed N, Wong WT, Ospino F, et al. Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity. Circulation. 2015 Jan 20;131(3):300-9. doi: 10.1161/CIRCULATIONAHA.113.007394
  65. Meng S, Lv J, Chanda PK, Owusu I, Chen K, Cooke JP. Reservoir of Fibroblasts Promotes Recovery From Limb Ischemia. Circulation. 2020 Oct 27;142(17):1647-62. doi: 10.1161/CIRCULATIONAHA.120.046872
  66. Cooke JP, Lai L. Role of angiogenic transdifferentiation in vascular recovery. Front Cardiovasc Med. 2023 May 2;10:1155835. doi: 10.3389/fcvm.2023.1155835
  67. Lai L, Reineke E, Hamilton DJ, Cooke JP. Glycolytic Switch Is Required for Transdifferentiation to Endothelial Lineage. Circulation. 2019 Jan 2;139(1):119-33. doi: 10.1161/CIRCULATIONAHA.118.035741
  68. Meng S, Zhou G, Gu Q, Chanda PK, Ospino F, Cooke JP. Transdifferentiation Requires iNOS Activation: Role of RING1A S-Nitrosylation. Circ Res. 2016 Oct 14;119(9):e129-e38. doi: 10.1161/CIRCRESAHA.116.308263
  69. Liu C, Ruan H, Himmati F, et al. HIF1alpha Regulates Early Metabolic Changes due to Activation of Innate Immunity in Nuclear Reprogramming. Stem Cell Reports. 2020 Feb 11;14(2):192-200. doi: 10.1016/j.stemcr.2020.01.006
  70. Feron O. The many metabolic sources of acetyl-CoA to support histone acetylation and influence cancer progression. Ann Transl Med. 2019 Dec;7(Suppl 8):S277. doi: 10.21037/atm.2019.11.140
  71. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011 Mar;21(3):381-95. doi: 10.1038/cr.2011.22
  72. Eberharter A, Becker PB. Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep. 2002 Mar;3(3):224-9. doi: 10.1093/embo-reports/kvf053
  73. Sterner DE, Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev. 2000 Jun;64(2):435-59. doi: 10.1128/MMBR.64.2.435-459.2000
  74. Lei I, Tian S, Gao W, et al. Acetyl-CoA production by specific metabolites promotes cardiac repair after myocardial infarction via histone acetylation. Elife. 2021 Dec 23;10:e60311. doi: 10.7554/eLife.60311
  75. Campbell SL, Wellen KE. Metabolic Signaling to the Nucleus in Cancer. Mol Cell. 2018 Aug 2;71(3):398-408. doi: 10.1016/j.molcel.2018.07.015
  76. Jing Y, Ding D, Tian G, et al. Semisynthesis of site-specifically succinylated histone reveals that succinylation regulates nucleosome unwrapping rate and DNA accessibility. Nucleic Acids Res. 2020 Sep 25;48(17):9538-49. doi: 10.1093/nar/gkaa663
  77. Zhang D, Tang Z, Huang H, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019 Oct;574(7779):575-80. doi: 10.1038/s41586-019-1678-1
  78. Sakabe K, Wang Z, Hart GW. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19915-20. doi: 10.1073/pnas.1009023107
DOI: https://doi.org/10.14797/mdcvj.1294 | Journal eISSN: 1947-6108
Language: English
Page range: 47 - 57
Submitted on: Sep 18, 2023
Accepted on: Sep 19, 2023
Published on: Nov 16, 2023
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2023 Naseeb Kaur Malhi, Kevin W. Southerland, Li Lai, Zhen Bouman Chen, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.